Science Current Events | Science News | Brightsurf.com
 

Thrombosis Current Events | Thrombosis News | 5

Sort By: Page Views | Date

Illegal drug use could account for 1 million visits a year to emergency care in England
Illegal drug use could account for up to 1 million visits a year to emergency care departments and 400,000 admissions to hospital in England, suggests research in Emergency Medicine Journal.   view more (2005-11-17)

Study shows pine bark naturally decreases severe chronic venous insufficiency
Recent findings published in the journal of Clinical and Applied Thrombosis/Hematosis show a significant symptom reduction of chronic venous insufficiency (CVI) in patients after supplementing with Pycnogenol® (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree.   view more (2006-07-13)

Key Found to Breakthrough Drug for Clot Victims
A team of researchers at Oregon Health & Science University and Washington University in St. Louis have described for the first time the mechanism that gives a mutant enzyme molecule that they have engineered - and patented - the potential to become a breakthrough drug for treating heart attacks and strokes.   view more (2008-03-11)

Anti-inflammatory effects of omega 3 fatty acid in fish oil linked to lowering of prostaglandin
Omega 3 fatty acids in dietary fish oil are reported to have anti-inflammatory and anti-thrombogenic and anti-arrhythmic effects in humans, but the biochemical basis for these beneficial health effects is not well understood.   view more (2006-04-04)

Early promise for treatment of Ebola (p 1953)
Embargoed 0001 h (London time) 12 December 2003. Preliminary findings of an animal study in this week's issue of THE LANCET suggest that scientists have taken an important step towards a possible treatment strategy for the deadly Ebola virus. Haemorragic fever from the Ebola virus is fatal in up to 80%of cases in humans. The virus is thought to... view more... (2003-12-10)

Nanotechnology enables low-dose treatment of atherosclerotic plaques
In laboratory tests, one very low dose of a drug was enough to show an effect on notoriously tenacious artery-clogging plaques. What kind of drug is that potent?   view more (2006-07-28)

Enoxaparin beats unfractionated heparin as adjunct therapy for heart attacks
A simple-to-use strategy that prevents blood clots in patients who have suffered a heart attack markedly reduces the risk of repeat heart attack or death when compared to an older, more widely used blood thinning strategy.   view more (2006-03-15)

Research highlights new approaches to prevent blood clots
Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured.   view more (2008-12-08)

Research shows fat fuels inflammation killer
New research by the University of Warwick's Warwick Medical School shows that the biggest health threat to fat and obese people isn't the fat itself but the fact that the fat fuels a killer inflammation response in people.   view more (2006-03-09)

New anti-thrombotic therapy effective, safer for patients
A Canadian-led study involving researchers from 41 countries has demonstrated in the world's largest study of acute coronary syndromes (ACS) that a new anti-thrombotic therapy is safer and as effective as the traditional therapy used in preventing heart attacks, death and ischemia in people with serious heart conditions.   view more (2005-09-06)

Aspirin treatment failure warning
Treatment failures occur with any drug and aspirin is no exception. Evidence is growing that some people will not respond to the anti-coagulant action of aspirin and the drug will not protect against cardiovascular events despite its regular intake.   view more (2005-08-10)

Better patient outcomes with drug eluting stents
Patients receiving drug eluting stents (DES) - stents coated with medication to prevent narrowing of the artery - as part of an angioplasty had better outcomes one year later than patients with bare metal stents, according to a new study to be published in CMAJ http://www.cmaj.ca/press/080050.pdf.   view more (2008-12-18)

UCSD researchers create roadmap to integrin activation
Calling it an important technical advance in the study of the complex receptors and pathways of the body's cellular system, researchers at the University of California, San Diego (UCSD) School of Medicine have reconstructed the signaling pathways that impact activation of a receptor that is critical to the control of bleeding and to the thrombosis... view more... (2006-09-18)

Morphochem Signs Deal With AstraZeneca To Develop Novel Anti-thrombotics
Munich, November 21st 2002 "¦. Morphochem AG, a leader in evolutionary discovery of small molecule drugs, has entered into a research collaboration with AstraZeneca AB (Sweden) wherein Morphochem will apply its drug discovery engine, the MOREsystem™, to the discovery of compounds with novel structures with activity against an... view more... (2002-11-21)

New risk factor for heart disease identified
Physicians can now identify overweight people at very high risk of developing heart disease, thanks to research published this week in BMC Cardiovascular Disorders. People who suffer from heart disease are more likely to produce smaller versions of a protein called apolipoprotein(a). Being overweight increases your risk of suffering from heart... view more... (2003-12-08)

Study points to new way to predict death risk from torn aorta
Each year, 10,000 Americans suffer a sudden tear in the lining of their body's largest blood vessel, the aorta. It's often misdiagnosed, and it can kill if not treated immediately. Actor John Ritter died of such a tear in 2003.   view more (2007-07-26)

ESC Congress 2003: In whom submitted to a percutaneous coronary intervention could we avoid stenting?
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Drug-eluting stents - a universal panacea A stent is a... view more... (2003-09-02)

1 in 10 patients comes to harm while in hospital
One in 10 NHS patients comes to harm while in hospital as a result of their clinical care, suggests a study in Quality and Safety in Health Care. (BMJ-British Medical Journal)   view more (2007-12-03)

U of Minnesota researchers examine the value of health information technology
University of Minnesota researchers found that the use of health information technology (IT), a popular health policy initiative, has had little or no effect on patient safety.   view more (2009-03-11)

Best use of drug-eluting stents
Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction.   view more (2008-09-02)
Sort By: Page Views | Date
© 2009 BrightSurf.com